Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 618-629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical comparison of weight‐ and age‐based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 3, 2015-05 ,pp. : 307-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytoreduction and Stem Cell Mobilization with a Regimen of Paclitaxel, Etoposide and Cyclophosphamide Followed by Autologous Transplantation Using a Preparative Regimen of Busulfan, Etoposide and Cyclophosphamide for Patients with Advanced Lymphoma

By  

Acta Haematologica, Vol. 105, Iss. 4, 2001-08 ,pp. : 222-232

Karger

Access to resources Recommend Favorite

Non‐total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 4, 2015-06 ,pp. : 422-427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of Busulfan and Cyclophosphamide Conditioning with Sleep Disorders after Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-09 ,pp. : 125-128

Karger

Access to resources Recommend Favorite